Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01 Clinical Trial Optional)

Archived

National Institutes of Health

Description

The health and preventive benefits of treatment for HIV/AIDS, regardless of CD4 count, are now unequivocal. In the United States and globally, ambitious goals have been targeted for HIV testing, adherence, and retention in care, to optimize HIV clinical outcomes and preventive benefit. Additional tools are needed to inform the gaps and strategies that are unique to particular populations, cities, regions, and countries. Applications appropriate for this FOA could include formative basic behavioral and social science to better understand a step in the care continuum and/or multiple steps in the HIV care continuum, initial development and pilot tests of innovative approaches for intervention, and intervention efficacy trials.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedNov 29, 2017
  • ClosesJan 7, 2020
  • CFDA93.242, 93.361
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro